Symons Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Symons Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$4.55M	Sell	76,862 -5,603	-7%	-$369K	2.92%	16
2021 Q2	$5.51M	Sell	82,465 -3,777	-4%	-$246K	3.14%	13
2021 Q1	$5.45M	Sell	86,242 -12,039	-12%	-$749K	2.85%	13
2020 Q4	$6.1M	Sell	98,281 -2,169	-2%	-$133K	3.36%	9
2020 Q3	$6.06M	Sell	100,450 -3,515	-3%	-$212K	3.72%	7
2020 Q2	$6.11M	Sell	103,965 -2,254	-2%	-$135K	3.88%	7
2020 Q1	$5.92M	Sell	106,219 -3,964	-4%	-$242K	3.46%	9
2019 Q4	$7.07M	Buy	110,183 +14,995	+16%	+$859K	3.67%	8
2019 Q3	$4.83M	Sell	95,188 -9,524	-9%	-$448K	2.22%	22
2019 Q2	$4.75M	Sell	104,712 -3,701	-3%	-$172K	1.97%	29
2019 Q1	$5.17M	Buy	108,413 +596	+0.6%	+$29.7K	2.23%	27
2018 Q4	$5.6M	Buy	+107,817	New	+$5.79M	2.33%	16

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Symons Capital Management's BMY Position: Q3 2021 in Review

Symons Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 6.8% in Q3 2021, selling an estimated $369K and leaving 76,862 shares worth $4.55M. The position accounts for 2.92% of the portfolio, ranked #16.

Symons Capital Management first reported a position in BMY in Q4 2018 and has held it in 12 quarters since. The position peaked at $7.07M in Q4 2019. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Symons Capital Management held 76,862 shares of Bristol-Myers Squibb worth $4.55M as of Q3 2021.
Symons Capital Management sold 5,603 Bristol-Myers Squibb shares in Q3 2021, an estimated $369K.
Bristol-Myers Squibb made up 2.92% of Symons Capital Management's portfolio in Q3 2021, its #16 holding.
Symons Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 12 quarters since.
Symons Capital Management's Bristol-Myers Squibb position peaked at $7.07M in Q4 2019.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Symons Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.